Transcriptional Control of COX-2 via C/EBP&bgr;

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2005-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1161/01.ATV.0000157899.35660.61PMID 15681294
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostaglandins and the Cardiovascular System.

  2025cited by this paper
• Ras induces mediator complex exchange on C/EBP beta.

  2004cited by this paper
• Coxibs and cardiovascular disease.

  2004cited by this paper
• Cyclooxygenase-2 Inhibitor Treatment Improves Left Ventricular Function and Mortality in a Murine Model of Doxorubicin-Induced Heart Failure

  2004cited by this paper
• Role of p300 and PCAF in regulating cyclooxygenase-2 promoter activation by inflammatory mediators.

  2004cited by this paper
• Up-regulation of p300 Binding and p50 Acetylation in Tumor Necrosis Factor-α-induced Cyclooxygenase-2 Promoter Activation*

  2003cited by this paper
• Salicylate Suppresses Macrophage Nitric-oxide Synthase-2 and Cyclo-oxygenase-2 Expression by Inhibiting CCAAT/Enhancer-binding Protein-β Binding via a Common Signaling Pathway*

  2002cited by this paper
• Role of Prostacyclin in the Cardiovascular Response to Thromboxane A2

  2002cited by this paper
• CCAAT/Enhancer-Binding Protein Decoy Oligodeoxynucleotide Inhibition of Macrophage-Rich Vascular Lesion Formation in Hypercholesterolemic Rabbits

  2002cited by this paper
• Dynamic Regulation of Cyclooxygenase-2 Promoter Activity by Isoforms of CCAAT/Enhancer-binding Proteins*

  2002cited by this paper
• Cyclooxygenase-2 Promotes Early Atherosclerotic Lesion Formation in LDL Receptor–Deficient Mice

  2002cited by this paper
• Effect of Low-Dose Aspirin on Vascular Inflammation, Plaque Stability, and Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice

  2002cited by this paper
• Obligatory Role of Cyclic Adenosine Monophosphate Response Element in Cyclooxygenase-2 Promoter Induction and Feedback Regulation by Inflammatory Mediators

  2002cited by this paper
• Purification and characterization of a cyclooxygenase‐2 and angiogenesis suppressing factor produced by human fibroblasts

  2002cited by this paper
• Cell cycle‐dependent expression of cyclooxygenase‐2 in human fibroblasts

  2001cited by this paper
• Selective Suppression of CCAAT/Enhancer-binding Protein β Binding and Cyclooxygenase-2 Promoter Activity by Sodium Salicylate in Quiescent Human Fibroblasts*

  2001cited by this paper
• Risk of cardiovascular events associated with selective COX-2 inhibitors.

  2001cited by this paper
• Overexpression of Functionally Coupled Cyclooxygenase-2 and Prostaglandin E Synthase in Symptomatic Atherosclerotic Plaques as a Basis of Prostaglandin E2-Dependent Plaque Instability

  2001cited by this paper
• Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice

  2001cited by this paper
• Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo.

  2001influential reference
• Selective inhibition of interleukin-4 gene expression in human T cells by aspirin.

  2001cited by this paper
• Shear Stress Differentially Regulates PGHS-1 and PGHS-2 Protein Levels in Human Endothelial Cells

  2000cited by this paper
• Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.

  2000cited by this paper
• The COX-2 inhibitor nimesulide suppresses superoxide and 8-hydroxy-deoxyguanosine formation, and stimulates apoptosis in mucosa during early colonic inflammation in rats.

  2000cited by this paper
• Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits.

  2000cited by this paper
• Colocalization of Prostacyclin Synthase with Prostaglandin H Synthase-1 (PGHS-1) but Not Phorbol Ester-induced PGHS-2 in Cultured Endothelial Cells*

  2000cited by this paper
• Xenobiotic-metabolizing Cytochromes P450 Convert Prostaglandin Endoperoxide to Hydroxyheptadecatrienoic Acid and the Mutagen, Malondialdehyde*

  2000cited by this paper
• Inhibition of cyclooxygenase-2 improves cardiac function in myocardial infarction.

  2000cited by this paper
• Proliferation is necessary for both repair and mutation in transgenic mouse cells.

  2000cited by this paper
• Transcriptional Activation of the Cyclooxygenase-2 Gene in Endotoxin-treated RAW 264.7 Macrophages*

  2000cited by this paper
• Overexpression of Cyclooxygenase-2 Induces Cell Cycle Arrest

  1999cited by this paper
• Salicylic acid and aspirin inhibit the activity of RSK2 kinase and repress RSK2-dependent transcription of cyclic AMP response element binding protein- and NF-kappa B-responsive genes.

  1999cited by this paper
• Malignant Transformation and Antineoplastic Actions of Nonsteroidal Antiinflammatory Drugs (Nsaids) on Cyclooxygenase-Null Embryo Fibroblasts

  1999cited by this paper
• CCAAT/enhancer-binding protein beta (C/EBPbeta) and C/EBPdelta contribute to growth hormone-regulated transcription of c-fos.

  1999cited by this paper
• Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBP beta is required for hepatocyte proliferation induced by TGF alpha.

  1999cited by this paper
• Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.

  1999cited by this paper
• Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction.

  1999cited by this paper
• Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate.

  1999cited by this paper
• Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions.

  1999cited by this paper
• Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.

  1999cited by this paper
• Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression.

  1999cited by this paper
• CCAAT/Enhancer-binding Protein β (C/EBPβ) and C/EBPδ Contribute to Growth Hormone-regulated Transcription of c-fos *

  1999cited by this paper
• Phosphorylation of Rat Serine 105 or Mouse Threonine 217 in C/EBPβ Is Required for Hepatocyte Proliferation Induced by TGFα

  1999cited by this paper
• The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta.

  1998cited by this paper
• Cyclooxygenase-2 induction in congestive heart failure: friend or foe?

  1998cited by this paper
• Injury-coupled induction of endothelial eNOS and COX-2 genes: a paradigm for thromboresistant gene therapy.

  1998cited by this paper
• The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β

  1998cited by this paper
• Injury-coupled induction of endothelial eNOS and COX-2 genes: a paradigm for thromboresistant gene therapy.

  1998cited by this paper
• Determination of aspirin and salicylic acid in human plasma by column-switching liquid chromatography using on-line solid-phase extraction.

  1998cited by this paper
• Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.

  1997cited by this paper
• NF-IL6 and NF-kappa B in cytokine gene regulation.

  1997cited by this paper
• Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2*

  1996cited by this paper
• Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress.

  1996cited by this paper
• G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2.

  1996cited by this paper
• Prostaglandin synthase 2.

  1996cited by this paper
• The effect of sodium salicylate and aspirin on NF-kappa B.

  1995cited by this paper
• Calcium-mediated Translocation of Cytosolic Phospholipase A2 to the Nuclear Envelope and Endoplasmic Reticulum (*)

  1995cited by this paper
• The C/EBP family of transcription factors.

  1995cited by this paper
• The Effect of Sodium Salicylate and Aspirin on NF-kappaB

  1995cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• Inducible cyclooxygenase and nitric oxide synthase.

  1995cited by this paper
• Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene.

  1994cited by this paper
• Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.

  1994cited by this paper
• Inhibition of NF-kappa B by sodium salicylate and aspirin.

  1994cited by this paper
• Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8.

  1993cited by this paper
• Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain

  1993cited by this paper
• Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6.

  1993cited by this paper
• Calcium-Regulated Phosphorylation Within the Leucine Zipper of C/EBPβ

  1992cited by this paper
• Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase.

  1992cited by this paper
• A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA.

  1991cited by this paper
• A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family.

  1990cited by this paper
• IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP.

  1990cited by this paper
• ALTERATIONS IN THE

  1985cited by this paper
• Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation.

  1984cited by this paper
• Prostaglandins and the cardiovascular system.

  1983cited by this paper
• The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.

  1975cited by this paper
• A restriction point for control of normal animal cell proliferation.

  1974cited by this paper
• Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

  1971cited by this paper
• CIRCULATION

  1964cited by this paper

• Exploring the Prospective Role of Propolis in Modifying Aging Hallmarks

  2024cites this paper
• Prostaglandin F2α requires activation of calcium-dependent signalling to trigger inflammation in human myometrium

  2023cites this paper
• Terpenes: Modulating anti-inflammatory signaling in inflammatory bowel disease.

  2023cites this paper
• Alpha‐enolase 1 knockdown facilitates the proliferation and invasion of villous trophoblasts by upregulating COX‐2

  2023cites this paper
• Identification of Hub Genes in the Pathogenesis of Ischemic Stroke Based on Bioinformatics Analysis

  2022cites this paper
• C/EBPδ drives key endocrine signals in the human amnion at parturition

  2021cites this paper
• Network Pharmacology-Based Prediction of Active Ingredients and Potential Targets of ShengDiHuang Decoction for Treatment of Dysfunctional Uterine Bleeding

  2020cites this paper
• Utilizing Network Pharmacology to Explore the Possible Mechanism of Coptidis Rhizoma in Kawasaki Disease

  2020cites this paper
• Role and Regulation of Mechanotransductive HIF-1α Stabilisation in Periodontal Ligament Fibroblasts

  2020cites this paper
• Cyclooxygenase‐2 is acutely induced by CCAAT/enhancer‐binding protein β to produce prostaglandin E 2 and F 2α following gonadotropin stimulation in Leydig cells

  2019cites this paper
• Saikosaponin-d Suppresses COX2 Through p-STAT3/C/EBPβ Signaling Pathway in Liver Cancer: A Novel Mechanism of Action

  2019cites this paper
• The potential importance of myeloid-derived suppressor cells (MDSCs) in the pathogenesis of Alzheimer’s disease

  2018cites this paper
• The Novel Nutraceutical KJS018A Prevents Hepatocarcinogenesis Promoted by Inflammation

  2018cites this paper
• The Study of Cyclooxygenase 2 in Human Decidua of Preeclampsia1

  2016cites this paper
• sn-1,2-diacylglycerols protect against lethal endotoxemia by controlling systemic inflammation.

  2016cites this paper
• Endothelium-Derived 5-Methoxytryptophan Is a Circulating Anti-Inflammatory Molecule That Blocks Systemic Inflammation.

  2016cites this paper
• A review of the molecular aspects of melatonin’s anti‐inflammatory actions: recent insights and new perspectives

  2013cites this paper
• C/EBPbeta3 (LIP) induces cell death in breast cancer cells

  2013cites this paper
• Regulació del metabolisme de l'àcid araquidònic i senyalització cel•lular en un model d'asma i intolerància als AINEs

  2013cites this paper
• A distal enhancer controls cytokine-dependent human cPLA2α gene expression[S]

  2013cites this paper
• Adherence junction proteins in angiogenesis: modulation by aspirin and salicylic acid

  2012cites this paper
• Regulation of human microsomal prostaglandin E synthase-1 by IL-1β requires a distal enhancer element with a unique role for C/EBPβ.

  2012cites this paper
• Signal Transduction Pathways (MAPKs, NF-κB, and C/EBP) Regulating COX-2 Expression in Nasal Fibroblasts from Asthma Patients with Aspirin Intolerance

  2012cites this paper
• Arachidonic acid regulation of the cytosolic phospholipase A 2α/cyclooxygenase-2 pathway in mouse endometrial stromal cells.

  2012cites this paper
• OxLDL up-regulates Niemann-Pick type C1 expression through ERK1/2/COX-2/PPARα-signaling pathway in macrophages.

  2012cites this paper
• Niacin promotes adipogenesis by reducing production of anti-adipogenic PGF2α through suppression of C/EBPβ-activated COX-2 expression.

  2011cites this paper
• Chemopreventive effect of saikosaponin-d on diethylinitrosamine-induced hepatocarcinogenesis: involvement of CCAAT/enhancer binding protein β and cyclooxygenase-2.

  2011cites this paper
• A Leaf Methanolic Extract of Wercklea insignis Attenuates the Lipopolysaccharide-Induced Inflammatory Response by Blocking the NF-κB Signaling Pathway in RAW 264.7 Macrophages

  2011cites this paper
• Fundamentals of Inflammation

  2010cites this paper
• Dihydro-N-caffeoyltyramine down-regulates cyclooxygenase-2 expression by inhibiting the activities of C/EBP and AP-1 transcription factors.

  2010cites this paper
• Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells

  2010cites this paper
• MiRNA‐26b regulates the expression of cyclooxygenase‐2 in desferrioxamine‐treated CNE cells

  2010cites this paper
• RNAi-Based Strategies for Cyclooxygenase-2 Inhibition in Cancer

  2010cites this paper
• C/EBP b regulates body composition, energy balance-related hormones and tumor growth

  2009cites this paper
• Runt-related transcription factor 1 regulates luteinized hormone-induced prostaglandin-endoperoxide synthase 2 expression in rat periovulatory granulosa cells.

  2009cites this paper
• C/EBPbeta regulates body composition, energy balance-related hormones and tumor growth.

  2009cites this paper
• Potent anti‐inflammatory effects of two quinolinedione compounds, OQ1 and OQ21, mediated by dual inhibition of inducible NO synthase and cyclooxygenase‐2

  2009cites this paper
• Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome.

  2009cites this paper
• Renal adverse effects of nonsteroidal anti-inflammatory drugs

  2009cites this paper
• Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.

  2009cites this paper
• MOLECULAR MECHANISMS FOR REGULATION OF GENE EXPRESSION BY LYSOPHOSPHATIDIC ACID IN OVARIAN CARCINOMA CELLS

  2009cites this paper
• Role of p53 in the induction of cyclooxygenase-2 by cisplatin or paclitaxel in non-small cell lung cancer cell lines.

  2009cites this paper
• MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells.

  2009cites this paper
• Oxidized Low Density Lipoprotein Activates Peroxisome Proliferator-activated Receptor-α (PPARα) and PPARγ through MAPK-dependent COX-2 Expression in Macrophages*

  2008cites this paper
• Lysophosphatidic acid-induced transactivation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E(2) release via C/EBPbeta in human bronchial epithelial cells.

  2008cites this paper
• Transcriptional and post‐transcriptional mechanisms for lysophosphatidic acid‐induced cyclooxygenase‐2 expression in ovarian cancer cells

  2008cites this paper
• CCAAT/enhancer binding protein β deficiency provides cerebral protection following excitotoxic injury

  2008cites this paper
• CCAAT/enhancer binding protein beta is a major mediator of inflammation and viral replication in the gastrointestinal tract of simian immunodeficiency virus-infected rhesus macaques.

  2008cites this paper
• Translationally regulated C/EBPβ isoform expression upregulates metastatic genes in hormone‐independent prostate cancer cells

  2008cites this paper
• Increased expression of CCAAT/enhancer‐binding protein beta in proliferative inflammatory atrophy of the prostate: Relation with the expression of COX‐2, the androgen receptor, and presence of focal chronic inflammation

  2007cites this paper
• Die Bedeutung von CCAAT/Enhancer Binding Protein (C/EBP) beta und Suppressor of Cytokine Signalling (SOCS) 1 & 3 für die Pathogenese der Amyotrophen Lateralsklerose (ALS)

  2007cites this paper
• An essential role for CCAAT/enhancer binding protein β in bleomycin‐induced pulmonary fibrosis

  2007cites this paper
• Limited role of COX-2 in HIV Tat-induced alterations of tight junction protein expression and disruption of the blood-brain barrier.

  2007cites this paper
• Effects of an ophthalmic formulation of meloxicam on COX-2 expression, PGE2 release, and cytokine expression in a model of acute ocular inflammation

  2007cites this paper
• Interferon-gamma suppresses cyclooxygenase-2 promoter activity by inhibiting C-Jun and C/EBPbeta binding.

  2007cites this paper
• Inhibition of lipopolysaccharide-stimulated NO production by a novel synthetic compound CYL-4d in RAW 264.7 macrophages involving the blockade of MEK4/JNK/AP-1 pathway.

  2007cites this paper
• CRE-mediated transcription and COX-2 expression in the pilocarpine model of status epilepticus.

  2007cites this paper
• Characterization of immunological activities of peanut stilbenoids, arachidin-1, piceatannol, and resveratrol on lipopolysaccharide-induced inflammation of RAW 264.7 macrophages.

  2007cites this paper
• Interferon-&ggr; Suppresses Cyclooxygenase-2 Promoter Activity by Inhibiting C-Jun and C/EBP&bgr; Binding

  2007cites this paper
• Salicylate-Based Anti-Inflammatory Drugs Inhibit the Early Lesion of Diabetic Retinopathy

  2007influential citation
• Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression.

  2007cites this paper
• The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells.

  2006cites this paper
• The role of the cylooxygenase pathway in nociception and pain.

  2006cites this paper
• The Cyclin-Dependent Kinase 2 Inhibitor Down-regulates Interleukin-1β-Mediated Induction of Cyclooxygenase-2 Expression in Human Lung Carcinoma Cells

  2006cites this paper
• Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB

  2006cites this paper
• [Cyclooxygenase-2: a new therapeutic target in atherosclerosis?].

  2006cites this paper
• Transcription-based COX-2 inhibition: A therapeutic strategy

  2006cites this paper
• Circulating interleukin-6 induces fever through a STAT3-linked activation of COX-2 in the brain.

  2006cites this paper
• Distinct patterns of intracerebral hemorrhage‐induced alterations in NF‐κB subunit, iNOS, and COX‐2 expression

  2006cites this paper
• Ciclooxigenasa 2: ¿una nueva diana terapéutica en la aterosclerosis?

  2006cites this paper
• Up-regulation of cyclooxygenase-2 by interleukin-1beta in colon carcinoma cells.

  2006cites this paper
• Expression in Human Lung Carcinoma Cells-Mediated Induction of Cyclooxygenase-2 β Interleukin-1 The Cyclin-Dependent Kinase 2 Inhibitor Down-regulates

  2006cites this paper